{"author_name":"CTD_GIM","height":"190","provider_name":"Hatena Blog","url":"https://ctd-gim.hatenablog.com/entry/2023/01/19/230108","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fctd-gim.hatenablog.com%2Fentry%2F2023%2F01%2F19%2F230108\" title=\"\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308bTocilizumab\u6295\u4e0e\u3068CRP\u306e\u95a2\u4fc2\u6027 - \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","blog_url":"https://ctd-gim.hatenablog.com/","image_url":null,"width":"100%","version":"1.0","blog_title":"\u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u4e00\u4eba\u6284\u8aad\u4f1a","published":"2023-01-19 23:01:08","title":"\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u304a\u3051\u308bTocilizumab\u6295\u4e0e\u3068CRP\u306e\u95a2\u4fc2\u6027","categories":["\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1","\u6cbb\u7642\u85ac"],"provider_url":"https://hatena.blog","description":"Ann Rheum Dis. 2020;79(7):874-882. Tocilizumab\uff08TCZ\uff09\u306f\u6297IL-6\u53d7\u5bb9\u4f53\u6297\u4f53\u3067\u3001\u6295\u4e0e\u3059\u308b\u3068CRP\u304c\u307b\u307c0\u306b\u306a\u308b\u7279\u6027\u304c\u3042\u308b\u3002\u305f\u3060\u3001CRP\u304c\u4f4e\u4e0b\u3059\u308b\u3053\u3068\u3068RA\u304c\u6539\u5584\u3059\u308b\u3053\u3068\u306e\u95a2\u9023\u306f\u3088\u304f\u308f\u304b\u3063\u3066\u3044\u306a\u3044\u3002\u305d\u306e\u95a2\u9023\u306b\u3064\u3044\u3066\u8abf\u3079\u305f\u7814\u7a76\u306f3\u3064\u3042\u3063\u305f\u304c\u3001\u6700\u3082\u30c7\u30fc\u30bf\u304c\u96c6\u307e\u3063\u3066\u3044\u3066\u8208\u5473\u6df1\u304b\u3063\u305f\u8ad6\u6587\u3092\u7c21\u5358\u306b\u307e\u3068\u3081\u3066\u307f\u305f\u3002 \u25ceResult \u25ce\u611f\u60f3","type":"rich","author_url":"https://blog.hatena.ne.jp/CTD_GIM/"}